Related references
Note: Only part of the references are listed.A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer
L. A. Selth et al.
ONCOGENE (2017)
MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma
Qiqi Mao et al.
TUMOR BIOLOGY (2016)
MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression
Chenli Li et al.
BMC CANCER (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1
Carsten Gram Hansen et al.
CELL RESEARCH (2015)
Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH
Juan He et al.
CLINICAL ENDOCRINOLOGY (2015)
Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer
Darina Kachakova et al.
DNA AND CELL BIOLOGY (2015)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer
Sven Wach et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm
Li-hui Yin et al.
LEUKEMIA RESEARCH (2015)
YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer
Gamze Kuser-Abali et al.
NATURE COMMUNICATIONS (2015)
miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
Nahyun Choi et al.
ONCOTARGET (2015)
MicroRNA-375 plays a dual role in prostate carcinogenesis
Pedro Costa-Pinheiro et al.
CLINICAL EPIGENETICS (2015)
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
H-M Lin et al.
BRITISH JOURNAL OF CANCER (2014)
The Emerging Role of miR-375 in Cancer
Jun-Wei Yan et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Matjaz Rokavec et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT
Yuanming Shen et al.
PLOS ONE (2014)
Addicted to secrete - novel concepts and targets in cancer therapy
Nicolas Dejeans et al.
TRENDS IN MOLECULAR MEDICINE (2014)
MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression
Lekun Fang et al.
ONCOTARGET (2014)
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
Martin Puhr et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
X-X He et al.
ONCOGENE (2012)
miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Eri Nishikawa et al.
CANCER RESEARCH (2011)
Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma
Jaroslaw Szczyrba et al.
MOLECULAR CANCER RESEARCH (2011)
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
Manav Korpal et al.
NATURE MEDICINE (2011)
Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
Guo-hai Shi et al.
ACTA PHARMACOLOGICA SINICA (2010)
MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.
Yasunori Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MiR-34a Attenuates Paclitaxel-Resistance of Hormone-Refractory Prostate Cancer PC3 Cells Through Direct and Indirect Mechanisms
Keitaro Kojima et al.
PROSTATE (2010)
Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
N. Bhatnagar et al.
CELL DEATH & DISEASE (2010)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
